Masato Karayama

Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study

Yasunori Enomoto, Yutaro Nakamura, Yasuomi Satake et al. · Respiratory Medicine · 2017 · 127 citations · Full text

Medicine, Pathology, Surgery +7

Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study

Yuzo Suzuki, Masato Karayama, Tomohiro Uto et al. · Journal of Thoracic Oncology · 2020 · 107 citations · Full text

Medicine, Immunology, Oncology +15

Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis

Yuzo Suzuki, Katsuhiro Yoshimura, Yasunori Enomoto et al. · Scientific Reports · 2018 · 104 citations · Full text

Medicine, Clinical Sciences, Radiology +17

Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer

Masato Karayama, Junichi Masuda, Kazutaka Mori et al. · Clinical & Translational Oncology · 2020 · 98 citations · Full text

Medicine, Oncology, Pharmacology +17

Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD

Yasuoki Horiike, Yuzo Suzuki, Tomoyuki Fujisawa et al. · Lara D. Veeken · 2019 · 94 citations

Life Sciences, Immunology, Pathology +13